Clarus Wealth Advisors purchased a new stake in shares of Xylem Inc (NYSE:XYL) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 3,520 shares of the industrial products company’s stock, valued at approximately $240,000.
Other institutional investors and hedge funds also recently bought and sold shares of the company. Chevy Chase Trust Holdings Inc. increased its holdings in Xylem by 0.9% in the 3rd quarter. Chevy Chase Trust Holdings Inc. now owns 197,184 shares of the industrial products company’s stock worth $12,349,000 after buying an additional 1,670 shares during the period. Highbridge Capital Management LLC acquired a new stake in shares of Xylem during the 3rd quarter worth approximately $254,000. Patten Group Inc. grew its stake in shares of Xylem by 295.6% during the 3rd quarter. Patten Group Inc. now owns 127,490 shares of the industrial products company’s stock worth $2,009,000 after purchasing an additional 95,259 shares during the period. Swiss National Bank grew its stake in shares of Xylem by 1.2% during the 3rd quarter. Swiss National Bank now owns 661,922 shares of the industrial products company’s stock worth $41,456,000 after purchasing an additional 8,100 shares during the period. Finally, Dynamic Technology Lab Private Ltd acquired a new stake in shares of Xylem during the 3rd quarter worth approximately $1,509,000. Hedge funds and other institutional investors own 85.07% of the company’s stock.
Shares of Xylem Inc (XYL) traded up $0.24 during trading hours on Thursday, hitting $73.55. The company had a trading volume of 284,201 shares, compared to its average volume of 1,095,419. The company has a quick ratio of 1.41, a current ratio of 1.88 and a debt-to-equity ratio of 0.87. The firm has a market cap of $13,069.49, a P/E ratio of 40.08, a price-to-earnings-growth ratio of 1.39 and a beta of 1.20. Xylem Inc has a 1 year low of $46.95 and a 1 year high of $76.81.
The company also recently announced a quarterly dividend, which will be paid on Thursday, March 15th. Shareholders of record on Thursday, February 15th will be given a $0.21 dividend. This is an increase from Xylem’s previous quarterly dividend of $0.18. This represents a $0.84 annualized dividend and a yield of 1.14%. The ex-dividend date is Wednesday, February 14th. Xylem’s payout ratio is currently 39.13%.
A number of brokerages have recently commented on XYL. Zacks Investment Research cut shares of Xylem from a “buy” rating to a “hold” rating in a research note on Tuesday. BMO Capital Markets reiterated a “buy” rating and set a $86.00 target price on shares of Xylem in a research report on Friday, February 2nd. Seaport Global Securities reiterated a “buy” rating and set a $83.00 target price on shares of Xylem in a research report on Friday, February 2nd. Oppenheimer increased their target price on Xylem to $82.00 and gave the company an “outperform” rating in a research report on Friday, February 2nd. Finally, Canaccord Genuity restated a “hold” rating and issued a $75.00 price objective on shares of Xylem in a report on Sunday, January 28th. Six research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. The company currently has an average rating of “Buy” and a consensus target price of $70.08.
In other news, Director Steven R. Loranger sold 47,712 shares of Xylem stock in a transaction dated Monday, December 18th. The stock was sold at an average price of $68.10, for a total value of $3,249,187.20. Following the completion of the transaction, the director now owns 68,843 shares in the company, valued at approximately $4,688,208.30. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Curtis J. Crawford sold 7,948 shares of Xylem stock in a transaction dated Thursday, February 8th. The shares were sold at an average price of $71.77, for a total value of $570,427.96. Following the completion of the transaction, the director now owns 55,245 shares of the company’s stock, valued at approximately $3,964,933.65. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 75,455 shares of company stock valued at $5,166,873. 0.75% of the stock is currently owned by corporate insiders.
TRADEMARK VIOLATION WARNING: This report was originally published by Week Herald and is owned by of Week Herald. If you are viewing this report on another website, it was illegally stolen and republished in violation of US and international trademark & copyright laws. The original version of this report can be accessed at https://weekherald.com/2018/02/15/clarus-wealth-advisors-acquires-shares-of-3520-xylem-inc-xyl.html.
Xylem Company Profile
Xylem Inc is a water technology company. The Company designs, manufactures and services engineered solutions across a range of critical applications. It is an equipment and service provider for water and wastewater applications with a portfolio of products and services addressing the cycle of water, from collection, distribution and use to the return of water to the environment.
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.